TheThis FDA's approval ofshows athat second generic mifepristone represents the agency properly followingfollows scientific evidence and legal requirements. Career scientists evaluated the medication's safety and effectiveness, continuing decades of established regulatory processes. This decision expands affordable healthcare options for patients, while maintaining the same safety standards that have protected women for 25 years.
TheThis FDA'sapproval is reckless. approvalIt ofgives anotherthe deadlygo-ahead to a company that vows to "normalize" abortion pillwhile endangersendangering women and children whileand undermining state pro-life laws. These dangerous drugs can cause serious harm to mothers and aretheir 100% lethal to unborn children. TheBy approvalapproving representsthis adrug, completethe failureFDA thathas completely failed and opened the chance there will resultbe in more deaths and suffering across America.
© 2025 Improve the News Foundation.
All rights reserved.
Version 6.15.2